|Bid||13.84 x 1200|
|Ask||13.99 x 2200|
|Day's Range||13.78 - 13.85|
|52 Week Range||12.61 - 19.95|
|Beta (3Y Monthly)||0.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||1.64 (11.76%)|
|1y Target Est||N/A|
DALLAS, July 18, 2019 /PRNewswire/ -- The Cushing® Renaissance Fund (NYSE: SZC) (the "Fund") announced the results of its transferable rights offering (the "Offer"). The Offer entitled rights holders to subscribe for up to an aggregate of 2,601,714 of the Fund's common shares of beneficial interest, par value $0.001 per share ("Common Shares"). The subscription price was $13.15 per Common Share and was determined based upon a formula equal to 78% of the Fund's net asset value ("NAV") per Common Share at the close of trading on the New York Stock Exchange ("NYSE") on the Expiration Date.
DALLAS, July 1, 2019 /PRNewswire/ -- The Cushing® Renaissance Fund (NYSE: SZC) declared a distribution for July 2019 of $0.1367 per common share. The Fund's distribution will be payable on July 31, 2019 to shareholders of record on July 3, 2019. The ex-date for the Fund's distribution is July 2, 2019. It is anticipated but not certain that approximately 43% of the Fund's distribution will be treated as a return of capital.
DALLAS, June 7, 2019 /PRNewswire/ -- The board of trustees (the "Board") of The Cushing® Renaissance Fund (NYSE: SZC) (the "Fund") has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common shares (the "Common Shareholders") of beneficial interest, par value $0.001 per share ("Common Shares"), as of the record date, entitling the holders of those Rights to subscribe for Common Shares (the "Offer"). The Board, based on the recommendations and presentations of the Fund's investment adviser, Cushing® Asset Management, LP ("Cushing" or the "Investment Adviser"), and others, has determined that it is in the best interests of the Fund and the Common Shareholders to conduct the Offer and thereby to increase the assets of the Fund available for investment.